严重精神疾病患者的现实生活决策:选择加入和选择退出研究参与。

IF 0.5 4区 医学 Q4 PSYCHIATRY
Amira Or, Yehuda Baruch, Shelly Tadger, Yoram Barak
{"title":"严重精神疾病患者的现实生活决策:选择加入和选择退出研究参与。","authors":"Amira Or,&nbsp;Yehuda Baruch,&nbsp;Shelly Tadger,&nbsp;Yoram Barak","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients' decisions in relation to participation in clinical research depend on individual values and relevant outcomes. Presenting possible decisions by way of defaults (opt-in or opt-out) has been used to achieve desired outcomes. Our objective was to characterize patients willing to participate in clinical research and to assess the impact of defaults on patients with Serious Mental Illness (schizophrenia, schizoaffective disorder, major depression and bipolar disorder; SMI) during the decision process.</p><p><strong>Methods: </strong>Patients with SMI were requested to accept or reject participation in a novel drug treatment study using either the (1) opt-in condition, wherein they were told that our center's policy is not to include them in drug studies; (2) the opt-out condition, wherein they were told that our center's policy is to include them in drug studies; and the (3) neutral condition that required patients to state their preference with no prior information.</p><p><strong>Results: </strong>311 patients with SMI completed the brief questionnaire within 48 hours of admission to a psychiatric ward. There were 227 (73%) patients suffering from schizophrenia and schizoaffective disorder, 40 (13%) suffering from bipolar disorder and 44 (14%) suffering from major depressive disorder. There were 156 men (50%) and 155 women in the sample, mean age 47.8±16.2 years. In the opt-in condition, 58% abstained, while 42% opted-in (p=0.003). In the opt-out condition, 58% participated, while 42% opted-out. In the neutral condition 51% indicated willingness to participate, 33% refused and 16% were undecided. The \"willing\" patient was characterized by younger age, previous hospitalizations, affective illness and more comorbid physical disorders.</p><p><strong>Conclusion: </strong>Taken together these findings reveal the \"profile\" of patients with SMI willing to participate in clinical research and demonstrate an increase in participation preferences through the use of defaults.</p>","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"51 3","pages":"199-203"},"PeriodicalIF":0.5000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participation.\",\"authors\":\"Amira Or,&nbsp;Yehuda Baruch,&nbsp;Shelly Tadger,&nbsp;Yoram Barak\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients' decisions in relation to participation in clinical research depend on individual values and relevant outcomes. Presenting possible decisions by way of defaults (opt-in or opt-out) has been used to achieve desired outcomes. Our objective was to characterize patients willing to participate in clinical research and to assess the impact of defaults on patients with Serious Mental Illness (schizophrenia, schizoaffective disorder, major depression and bipolar disorder; SMI) during the decision process.</p><p><strong>Methods: </strong>Patients with SMI were requested to accept or reject participation in a novel drug treatment study using either the (1) opt-in condition, wherein they were told that our center's policy is not to include them in drug studies; (2) the opt-out condition, wherein they were told that our center's policy is to include them in drug studies; and the (3) neutral condition that required patients to state their preference with no prior information.</p><p><strong>Results: </strong>311 patients with SMI completed the brief questionnaire within 48 hours of admission to a psychiatric ward. There were 227 (73%) patients suffering from schizophrenia and schizoaffective disorder, 40 (13%) suffering from bipolar disorder and 44 (14%) suffering from major depressive disorder. There were 156 men (50%) and 155 women in the sample, mean age 47.8±16.2 years. In the opt-in condition, 58% abstained, while 42% opted-in (p=0.003). In the opt-out condition, 58% participated, while 42% opted-out. In the neutral condition 51% indicated willingness to participate, 33% refused and 16% were undecided. The \\\"willing\\\" patient was characterized by younger age, previous hospitalizations, affective illness and more comorbid physical disorders.</p><p><strong>Conclusion: </strong>Taken together these findings reveal the \\\"profile\\\" of patients with SMI willing to participate in clinical research and demonstrate an increase in participation preferences through the use of defaults.</p>\",\"PeriodicalId\":49288,\"journal\":{\"name\":\"Israel Journal of Psychiatry and Related Sciences\",\"volume\":\"51 3\",\"pages\":\"199-203\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Israel Journal of Psychiatry and Related Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Israel Journal of Psychiatry and Related Sciences","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:患者参与临床研究的决定取决于个人价值观和相关结果。通过默认方式(选择加入或选择退出)呈现可能的决策已被用于实现预期的结果。我们的目的是描述愿意参与临床研究的患者的特征,并评估违约对患有严重精神疾病(精神分裂症、分裂情感障碍、重度抑郁症和双相情感障碍;SMI)。方法:要求重度精神障碍患者接受或拒绝参与一项新型药物治疗研究,采用(1)选择加入条件,其中他们被告知我们中心的政策是不将他们纳入药物研究;(2)选择退出条件,即他们被告知本中心的政策是将他们纳入药物研究;(3)中性条件,要求患者在没有先验信息的情况下陈述自己的偏好。结果:311例重度精神障碍患者在入住精神科病房48小时内完成了简短的问卷调查。其中精神分裂症和分裂情感性障碍227例(73%),双相情感障碍40例(13%),重度抑郁症44例(14%)。男性156例(50%),女性155例,平均年龄47.8±16.2岁。在选择加入条件下,58%的人弃权,42%的人选择加入(p=0.003)。在选择退出的情况下,58%的人参与,42%的人选择退出。在中性条件下,51%的人表示愿意参加,33%的人拒绝参加,16%的人犹豫不决。“自愿”患者的特点是年龄较小,既往住院,情感性疾病和更多的共病性身体疾病。结论:综上所述,这些发现揭示了重度精神障碍患者愿意参与临床研究的“概况”,并表明通过使用默认值,参与偏好有所增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participation.

Background: Patients' decisions in relation to participation in clinical research depend on individual values and relevant outcomes. Presenting possible decisions by way of defaults (opt-in or opt-out) has been used to achieve desired outcomes. Our objective was to characterize patients willing to participate in clinical research and to assess the impact of defaults on patients with Serious Mental Illness (schizophrenia, schizoaffective disorder, major depression and bipolar disorder; SMI) during the decision process.

Methods: Patients with SMI were requested to accept or reject participation in a novel drug treatment study using either the (1) opt-in condition, wherein they were told that our center's policy is not to include them in drug studies; (2) the opt-out condition, wherein they were told that our center's policy is to include them in drug studies; and the (3) neutral condition that required patients to state their preference with no prior information.

Results: 311 patients with SMI completed the brief questionnaire within 48 hours of admission to a psychiatric ward. There were 227 (73%) patients suffering from schizophrenia and schizoaffective disorder, 40 (13%) suffering from bipolar disorder and 44 (14%) suffering from major depressive disorder. There were 156 men (50%) and 155 women in the sample, mean age 47.8±16.2 years. In the opt-in condition, 58% abstained, while 42% opted-in (p=0.003). In the opt-out condition, 58% participated, while 42% opted-out. In the neutral condition 51% indicated willingness to participate, 33% refused and 16% were undecided. The "willing" patient was characterized by younger age, previous hospitalizations, affective illness and more comorbid physical disorders.

Conclusion: Taken together these findings reveal the "profile" of patients with SMI willing to participate in clinical research and demonstrate an increase in participation preferences through the use of defaults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.80
自引率
25.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: THE ISRAEL JOURNAL OF PSYCHIATRY publishes original articles dealing with the all bio-psycho-social aspects of psychiatry. While traditionally the journal has published manuscripts relating to mobility, relocation, acculturation, ethnicity, stress situations in war and peace, victimology and mental health in developing countries, papers addressing all aspects of the psychiatry including neuroscience, biological psychiatry, psychopharmacology, psychotherapy and ethics are welcome. The Editor also welcomes pertinent book reviews and correspondence. Preference is given to research reports of no more than 5,000 words not including abstract, text, references, tables and figures. There should be no more than 40 references and 4 tables or figures. Brief reports (1,500 words, 5 references) are considered if they have heuristic value. Books to be considered for review should be sent to the editorial office. Selected book reviews are invited by the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信